The diagnostic application of GLI1, as well p16 immunohistochemical staining, was analyzed in a cohort of GLI1-altered neoplasms, comprising equal numbers of GLI1-amplified and GLI1-rearranged tumors. This evidence concerns the gene GLI1 and neoplasm.